Only half of patients with metastatic castration-resistant prostate cancer were tested for HRR mutations, and PARP inhibitors were underused.
Prostate Cancer
A collection of feature articles, study abstracts, and other resources all focused on prostate cancer.
Men with metastatic hormone-sensitive prostate cancer who experience baseline bone pain have worse survival outcomes despite ...
Various sessions at the 2024 ASCO Genitourinary Cancers Symposium reviewed healthcare discrimination and disparities among ...
Researchers emphasized the importance of bone-protective agents in patients treated for metastatic castration-resistant ...
Researchers found correlations between PSMA PET total tumor burden and survival in patients with high-volume metastatic ...
Test your knowledge of the latest prostate cancer studies and news—take this quiz!
The following is a summary of "Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically…
Relevant Articles
Quiz yourself on ovarian cancer: early detection, biomarkers, and TP53 mutations per NCCN guidelines.
Researchers examined the key challenges associated with concomitant use of novel chronic lymphocytic leukemia therapies.
Kristen Wheeden, DrPH, MBA, discusses porphyria—the rare “vampire” disease—its stigma, and advances in patient care.
A systematic review examined how various surgical procedures for hepatocellular carcinoma impacted patients’ HRQoL over ...
Higher plasma-to-red cell transfusion ratios resulted in significantly lower mortality in trauma-induced critical bleeding.
Take this short quiz to assess your understanding of CLL/SLL biology, presentation, and epidemiology.
Doctor's Voice
In this fictitious tale, a vampire OB/GYN fights to save her women’s health clinic.
Suicide rates are rising in the US, especially among healthcare workers—Yvette Terrie, RPh, shares how awareness saves ...
Dr. Frank Brodkey dispels the myth that high-dose IV vitamin C is beneficial in sepsis treatment.
Prof. Pat Price calls for global investment in radiotherapy to ensure access to life-saving, precision cancer treatment.
At 19, Eldiara Doucette faced rare sarcoma and arm amputation, but turned her grief into empowerment and resilience.
Physicians must defend science, counter misinformation, and protect public health from politics.
